Second Sight (EYES) is trading 186% higher at $5.27 today.
The share price is rocketing upwards today. Shareholders had recently approved a merger, a reverse stock split, and a name change. Could this be the catalyst for today's move?
Second Sight has been trading between a 52-week high of $5.45 and a 52-week low of $1.14. The stock has a market cap of $208 Million.
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals.